Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease-Reference-Cited by-同舟云学术

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease

Published:2023-08 Issue: Volume:89 Page:101979
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Nowell Joseph,Blunt Eleanor,Gupta Dhruv,Edison Paul^ORCID

Publisher

Elsevier BV

Subject

Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology

Reference267 articles.

1. Depression in Parkinson disease--epidemiology, mechanisms and management;Aarsland;Nat. Rev. Neurol.,2011

2. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFkappaB and Nrf2-antioxidant signaling pathways;Abdelsalam;J. Neurochem,2015

3. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition;Adler;Neurobiol. Aging,2014

4. Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake;Adriaenssens;Cell Metab.,2019

5. Alzheimer's Disease International, 2018. World Alzheimer Report 2018: The state of the art of dementia research: New frontiers. Alzheimer's Disease International, London.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-state analysis of disease trajectories and mental health transitions in patients with type 2 diabetes: A population-based retrospective cohort study utilizing health administrative data;Diabetes Research and Clinical Practice;2024-02

2. Association between Type 1 Diabetes Mellitus and Parkinson’s Disease: A Mendelian Randomization Study;Journal of Clinical Medicine;2024-01-18

3. Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study;European Journal of Medical Research;2024-01-16

4. Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease;International Journal of Molecular Sciences;2023-11-12

5. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07